PL400308A1 - Terapia immunizacyjna w oparciu o peptydy do leczenia miazdzycy oraz w oparciu o peptydy do okreslania odpowiedzi odpornosci przeciwko utlenionym lipoproteinom o niskiej gestosci - Google Patents

Terapia immunizacyjna w oparciu o peptydy do leczenia miazdzycy oraz w oparciu o peptydy do okreslania odpowiedzi odpornosci przeciwko utlenionym lipoproteinom o niskiej gestosci

Info

Publication number: PL400308A1
Authority: PL; Poland
Prior art keywords: peptides; determination; immune response; low density; response against
Prior art date: 2001-04-05

Application number

PL400308A

Other languages

English (en)

Inventor

Jan Nilson

Prediman K. Shah

Original Assignee

Forskarpatent I Syd Ab

Cedars Sinai Medical Center

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-05

Filing date

2002-04-05

Publication date

2012-12-17

2001-04-05 Priority claimed from SE0101232A external-priority patent/SE0101232D0/xx

2002-04-05 Application filed by Forskarpatent I Syd Ab, Cedars Sinai Medical Center filed Critical Forskarpatent I Syd Ab

2012-12-17 Publication of PL400308A1 publication Critical patent/PL400308A1/pl

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Cardiology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Heart & Thoracic Surgery (AREA)
Genetics & Genomics (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Hematology (AREA)
Marine Sciences & Fisheries (AREA)
Toxicology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)

PL400308A 2001-04-05 2002-04-05 Terapia immunizacyjna w oparciu o peptydy do leczenia miazdzycy oraz w oparciu o peptydy do okreslania odpowiedzi odpornosci przeciwko utlenionym lipoproteinom o niskiej gestosci PL400308A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0101232A SE0101232D0 (sv)	2001-04-05	2001-04-05	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based elisa for determination of immune responses against oxidized low density liprotein
SE0103754A SE0103754L (sv)	2001-04-05	2001-11-09	Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid

Publications (1)

Publication Number	Publication Date
PL400308A1 true PL400308A1 (pl)	2012-12-17

Family

ID=26655437

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
PL400308A PL400308A1 (pl)	2001-04-05	2002-04-05	Terapia immunizacyjna w oparciu o peptydy do leczenia miazdzycy oraz w oparciu o peptydy do okreslania odpowiedzi odpornosci przeciwko utlenionym lipoproteinom o niskiej gestosci
PL02367301A PL367301A1 (pl)	2001-04-05	2002-04-05	Terapia immunizacyjna w oparciu o peptydy do leczenia miażdżycy oraz test w oparciu o peptydy do określania odpowiedzi odpornościowej przeciwko utlenionym lipoproteinom o niskiej gęstości
PL385189A PL215401B1 (pl)	2001-04-05	2002-04-05	Fragment apolipoproteiny B lub jego miejsce aktywne, zawierajaca go kompozycja farmaceutyczna i szczepionka, zastosowanie tego fragmentu , szczepionka zawierajaca przeciwcialo przeciwko temu fragmentowi, sposób diagnozowania in vitro oraz zastosowanie tego przeciwciala
PL391615A PL217858B1 (pl)	2001-04-05	2002-04-05	Fragment apolipoproteiny B lub jego miejsce aktywne, zawierająca go kompozycja farmaceutyczna i szczepionka, zastosowanie tego fragmentu, szczepionka zawierająca przeciwciało przeciwko temu fragmentowi, sposób diagnozowania in vitro oraz zastosowanie tego przeciwciała

Family Applications After (3)

Application Number	Title	Priority Date	Filing Date
PL02367301A PL367301A1 (pl)	2001-04-05	2002-04-05	Terapia immunizacyjna w oparciu o peptydy do leczenia miażdżycy oraz test w oparciu o peptydy do określania odpowiedzi odpornościowej przeciwko utlenionym lipoproteinom o niskiej gęstości
PL385189A PL215401B1 (pl)	2001-04-05	2002-04-05	Fragment apolipoproteiny B lub jego miejsce aktywne, zawierajaca go kompozycja farmaceutyczna i szczepionka, zastosowanie tego fragmentu , szczepionka zawierajaca przeciwcialo przeciwko temu fragmentowi, sposób diagnozowania in vitro oraz zastosowanie tego przeciwciala
PL391615A PL217858B1 (pl)	2001-04-05	2002-04-05	Fragment apolipoproteiny B lub jego miejsce aktywne, zawierająca go kompozycja farmaceutyczna i szczepionka, zastosowanie tego fragmentu, szczepionka zawierająca przeciwciało przeciwko temu fragmentowi, sposób diagnozowania in vitro oraz zastosowanie tego przeciwciała

Country Status (18)

Country	Link
EP (42)	EP2147928A3 (pl)
JP (6)	JP2004529143A (pl)
CN (4)	CN103122031B (pl)
AT (2)	ATE510851T1 (pl)
AU (1)	AU2002246484B8 (pl)
BR (1)	BR0208685A (pl)
CA (3)	CA2827167A1 (pl)
CY (1)	CY1108817T1 (pl)
DE (1)	DE60230029D1 (pl)
DK (3)	DK2006301T3 (pl)
EE (2)	EE200700052A (pl)
ES (2)	ES2546293T3 (pl)
IL (4)	IL158285A0 (pl)
PL (4)	PL400308A1 (pl)
PT (1)	PT1383526E (pl)
RU (1)	RU2296582C2 (pl)
SE (1)	SE0103754L (pl)
WO (1)	WO2002080954A1 (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0103754L (sv) *	2001-04-05	2002-10-06	Forskarpatent I Syd Ab	Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
US20030105003A1 (en)	2001-04-05	2003-06-05	Jan Nilsson	Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
CA2460787A1 (en)	2001-09-28	2003-04-03	Esperion Therapeutics, Inc.	Prevention and treatment of restenosis by local administration of drug
SE0302312D0 (sv) *	2002-10-04	2003-08-27	Forskarpatent I Syd Ab	Peptide-based passive immunization therapy for treatment of atherosclerosis
AU2003267905B2 (en) *	2002-10-04	2009-02-05	Biolnvent International Ab	Peptide-based passive immunization therapy for treatment of atherosclerosis
SE0302422D0 (sv) *	2003-09-11	2003-09-11	Forskarpatent I Syd Ab	Peptide-based immunization therapy for treatment of atherosclerosis
SE0400683D0 (sv)	2004-03-19	2004-03-19	Forskarpatent I Syd Ab	Use of modified extracellular matrix proteins in diagnosis and treatment of a atherosclerosis
JP2007531537A (ja)	2004-04-06	2007-11-08	セダーズ−シナイ　メディカル　センター	アポリポタンパク質ａ−ｉおよびアポリポタンパク質ａ−ｉｍｉｌａｎｏをコードする組換えアデノ随伴ウイルスベクターによる血管疾患の予防および処置
DE602005023428D1 (de)	2004-04-15	2010-10-21	Athera Biotechnologies Ab	Verfahren zur Feststellung der Gefahren von ischemischen Herzgefässerkrankungen mit PhosphorylcholinKonjugaten
EP1676602A1 (en) *	2005-01-04	2006-07-05	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis
GB0517878D0 (en)	2005-09-02	2005-10-12	Bioinvent Int Ab	Immunotherapeutic treatment
BRPI0720215A2 (pt) *	2006-12-22	2013-12-24	Abbott Lab	Painel de doença autoimune cardiovascular e métodos de usar o mesmo.
WO2008104194A1 (en) *	2007-02-28	2008-09-04	Bioinvent International Ab	Oxidized ldl and antibodies thereto for the treatment of atheroscleroti c plaques
JP5550352B2 (ja)	2007-03-15	2014-07-16	ノバルティスアーゲー	有機化合物およびその使用
DK2538222T3 (da) *	2007-11-05	2021-11-15	Nordic Bioscience As	Biokemiske markører til cvd-risikovurdering
US20100041663A1 (en)	2008-07-18	2010-02-18	Novartis Ag	Organic Compounds as Smo Inhibitors
CN102099470B (zh) *	2008-08-15	2014-11-12	藤仓化成株式会社	用于诊断动脉硬化的多肽标记、用该标记等检测动脉硬化的方法以及用于诊断动脉硬化的试剂盒
JP2013510586A (ja) *	2009-11-14	2013-03-28	チュウ、カン−ユウ	アテローム性動脈硬化を治療及び／又は予防するための免疫調節方法及びシステム
US8506964B2 (en) *	2010-02-05	2013-08-13	Cardiovax, Llc	Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
US20130142760A1 (en)	2010-08-18	2013-06-06	Cedars-Sinai Medical Center	Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using apo a-i milano gene transfer
RU2013126626A (ru)	2010-11-12	2014-12-20	Седарс-Синаи Медикал Сентер	Иммуномодулирующие способы и системы для лечения и/или предотвращения гипертензий
EP2637685A1 (en) *	2010-11-12	2013-09-18	Cedars-Sinai Medical Center	Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
CA2817548A1 (en) *	2010-11-12	2012-05-18	Cedars-Sinai Medical Center	Immunomodulatory compositions, methods and systems comprising immunogenic fragments of apob100
JP6277126B2 (ja)	2011-08-09	2018-02-07	アセラ・バイオテクノロジーズ・アーベー	ホスホリルコリン（ｐｃ）および／またはｐｃコンジュゲートに結合する抗体
BR112014002929A8 (pt)	2011-08-09	2021-09-28	Athera Biotechnologies Ab	Novos anticorpos contra fosforilcolina
RU2495048C1 (ru) *	2012-04-18	2013-10-10	Андрей Валентинович Исаев	Пептид, обладающий антиатеросклеротическим действием и композиция для профилактики и лечения атеросклероза сосудов
RU2662973C2 (ru)	2012-11-06	2018-07-31	Лез Опито Юниверситер Де Женев	Пептидомиметики
CN103520713B (zh) *	2013-10-16	2015-10-28	西北农林科技大学	一种ApoB100酵母重组疫苗及其制备方法和应用
CN103860470A (zh) *	2014-03-05	2014-06-18	贵州中泰生物科技有限公司	一种口服高密度脂蛋白脂质体的制备方法
CN105315364B (zh) *	2014-06-17	2018-09-18	广州文瑞生物科技有限公司	胶原蛋白vi疫苗预防动脉粥样硬化
US11130798B2 (en)	2015-05-19	2021-09-28	La Jolla Institute For Allergy And Immunology	Human APOB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosis
US10858422B2 (en)	2016-05-31	2020-12-08	Abcentra, Llc	Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
CN108478817B (zh) *	2018-03-16	2020-10-27	北京大学	一种动脉粥样硬化检测试剂及其制备方法
CA3101767A1 (en)	2018-05-29	2019-12-05	Abcentra, Llc	Compositions and methods for treatment of psoriasis
CA3129373A1 (en)	2018-05-29	2019-12-05	Abcentra, Llc	Compositions and methods for treatment of rheumatoid arthritis and accelerated atherosclerosis
CN115025210B (zh) *	2021-03-05	2025-09-05	香港中文大学	减少动脉粥样硬化进展的肽疫苗组合物和药物制剂
CN115025211A (zh) *	2021-11-02	2022-09-09	南京理工大学	用于动脉粥样硬化治疗的纳米疫苗及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4970144A (en)	1984-12-31	1990-11-13	International Genetic Engineering	Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
US5972890A (en)	1988-05-02	1999-10-26	New England Deaconess Hospital Corporation	Synthetic peptides for arterial imaging
WO1993018067A1 (en) *	1992-03-06	1993-09-16	Abbott Laboratories	Immunocapture assay for direct quantitation of specific lipoprotein cholesterol levels
WO1994000592A1 (en) *	1992-06-26	1994-01-06	Exocell, Inc.	Monoclonal antibodies against glycated low density lipoprotein
DE69332485T2 (de) *	1992-08-11	2003-11-13	The President And Fellows Of Harvard College, Cambridge	Immunmodulierende peptide
KR0185334B1 (ko)	1995-11-02	1999-04-01	김은영	인간 혈장 아포지단백질 비-100에 결합하는 생쥐 항체를 암호하는 씨디엔에이
GB9609702D0 (en) *	1996-05-09	1996-07-10	Royal Free Hosp School Med	Anticoagulant peptides
GB9620153D0 (en) *	1996-09-27	1996-11-13	Univ Strathclyde	Non-naturally occurring lipoprotein particle
GB9705831D0 (en) *	1997-03-20	1997-05-07	Univ Leicester	Oxidised ldl
US6635623B1 (en) *	1997-06-13	2003-10-21	Baylor College Of Medicine	Lipoproteins as nucleic acid vectors
US6225070B1 (en)	1997-08-07	2001-05-01	The Regents Of The University Of California	Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
US6156315A (en) *	1997-10-10	2000-12-05	The Trustees Of Columbia University In The City Of New York	Method for inhibiting the binding of low density lipoprotein to blood vessel matrix
US6309844B1 (en) *	1997-10-15	2001-10-30	Fujirebio Inc.	Anti-apo-B-48 monoclonal antibody, hybridoma producing the same, and method for measuring apo-B-48 using the same
EP1062512A4 (en) *	1998-03-10	2001-12-12	Univ California	METHODS AND TOOLS USED TO IDENTIFY COMPOUNDS THAT MODULATE ATHEROSCLEROSIS BY ALTERATION OF THE LDL-PROTEOGLYCANE BINDING
AU5200699A (en) *	1998-07-13	2000-02-01	University Of Otago	Inhibition of lipoprotein formation
IL126447A (en) *	1998-10-04	2004-09-27	Vascular Biogenics Ltd	An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
MXPA02004244A (es) *	1999-10-26	2002-11-04	Univ California	Reactivos y metodos para el diagnostico, la formacion de imagenes y el tratamiento del padecimiento de la ateroesclerosis..
AU3087801A (en) *	2000-02-04	2001-08-14	Molecular Dynamics Inc	Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells
US20030165503A1 (en) *	2000-03-03	2003-09-04	Jean-Charles Fruchart	Vaccine for the treatment of atherosclerosis
SE0000855D0 (sv) *	2000-03-15	2000-03-15	Karolinska Innovations Ab	Antigenic composition useful as a vaccine against atherosclerosis
GB0017641D0 (en) *	2000-07-18	2000-09-06	Medigene Oy	Peptides and their use
EP1186299A1 (en) *	2000-09-12	2002-03-13	Universitair Medisch Centrum Utrecht	The diagnosis, prevention, and/or succesful treatment of atherosclerosis, infectious diseases, and disturbances in the immune system
JP2004529080A (ja) *	2000-10-25	2004-09-24	アグネッロ，ヴィンセント	Ｈｃｖ、他のフラビウイルス科ウイルス、および血液中で低密度リポタンパク質または超低密度リポタンパク質と複合体を形成するその他のあらゆるウイルスによる感染を細胞中へのウイルス侵入を抑制することによって防止する方法
AU2002241603A1 (en) *	2000-11-10	2002-06-03	University Of Utah Research Foundation	Carrier system for specific artery wall gene delivery
SE0103754L (sv) *	2001-04-05	2002-10-06	Forskarpatent I Syd Ab	Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
RU2003136090A (ru) *	2001-05-15	2005-04-20	Джэпэн Иммьюнорисерч Лэборэтериз Ко., Лтд (Jp)	Пептид, взаимодействующий с липопротеином высокой плотности
EP1469887A4 (en) *	2001-07-20	2006-01-11	Eidgenoess Tech Hochschule	COMPOSITIONS AND METHODS FOR THE USE OF BIOACTIVE AGENTS DERIVED FROM SULFATE AND SULFONIC ACIDS

2001
- 2001-11-09 SE SE0103754A patent/SE0103754L/xx not_active Application Discontinuation
2002
- 2002-04-05 CN CN201210322795.9A patent/CN103122031B/zh not_active Expired - Lifetime
- 2002-04-05 EP EP08158141A patent/EP2147928A3/en not_active Withdrawn
- 2002-04-05 EP EP10180091A patent/EP2305706A1/en not_active Withdrawn
- 2002-04-05 EP EP10180111A patent/EP2289914A1/en not_active Withdrawn
- 2002-04-05 EP EP10180845A patent/EP2289924A1/en not_active Withdrawn
- 2002-04-05 EP EP10180168A patent/EP2295461A1/en not_active Withdrawn
- 2002-04-05 EP EP08167532A patent/EP2147680A3/en not_active Withdrawn
- 2002-04-05 AT AT08151489T patent/ATE510851T1/de not_active IP Right Cessation
- 2002-04-05 EP EP10181167A patent/EP2289925A1/en not_active Withdrawn
- 2002-04-05 EP EP10181196A patent/EP2289928A1/en not_active Withdrawn
- 2002-04-05 BR BR0208685-9A patent/BR0208685A/pt not_active Application Discontinuation
- 2002-04-05 CN CNA2009100095655A patent/CN101486766A/zh active Pending
- 2002-04-05 EP EP10180188A patent/EP2289916A1/en not_active Withdrawn
- 2002-04-05 EP EP10180184A patent/EP2295462A1/en not_active Withdrawn
- 2002-04-05 EP EP10181245A patent/EP2289933A1/en not_active Withdrawn
- 2002-04-05 CA CA2827167A patent/CA2827167A1/en not_active Abandoned
- 2002-04-05 EP EP10181273A patent/EP2289935A1/en not_active Withdrawn
- 2002-04-05 EP EP10180199A patent/EP2289918A1/en not_active Withdrawn
- 2002-04-05 PT PT02714667T patent/PT1383526E/pt unknown
- 2002-04-05 EP EP10180156A patent/EP2295459A1/en not_active Withdrawn
- 2002-04-05 WO PCT/SE2002/000679 patent/WO2002080954A1/en not_active Ceased
- 2002-04-05 IL IL15828502A patent/IL158285A0/xx unknown
- 2002-04-05 DK DK08151489.5T patent/DK2006301T3/da active
- 2002-04-05 EP EP10181253.5A patent/EP2289934B1/en not_active Expired - Lifetime
- 2002-04-05 ES ES10181267.5T patent/ES2546293T3/es not_active Expired - Lifetime
- 2002-04-05 EP EP10181217A patent/EP2289931A1/en not_active Withdrawn
- 2002-04-05 EP EP02714667A patent/EP1383526B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP07119130A patent/EP1918300A3/en not_active Withdrawn
- 2002-04-05 CA CA2443223A patent/CA2443223C/en not_active Expired - Lifetime
- 2002-04-05 PL PL400308A patent/PL400308A1/pl unknown
- 2002-04-05 RU RU2003132443/15A patent/RU2296582C2/ru active
- 2002-04-05 EP EP10180172A patent/EP2289915A1/en not_active Withdrawn
- 2002-04-05 EP EP08151489A patent/EP2006301B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP10181188A patent/EP2289927A1/en not_active Withdrawn
- 2002-04-05 EP EP10180162.9A patent/EP2295460B1/en not_active Expired - Lifetime
- 2002-04-05 DK DK02714667T patent/DK1383526T3/da active
- 2002-04-05 EP EP10180835A patent/EP2289922A1/en not_active Withdrawn
- 2002-04-05 DE DE60230029T patent/DE60230029D1/de not_active Expired - Lifetime
- 2002-04-05 EP EP10181173A patent/EP2289926A1/en not_active Withdrawn
- 2002-04-05 JP JP2002578993A patent/JP2004529143A/ja not_active Withdrawn
- 2002-04-05 AU AU2002246484A patent/AU2002246484B8/en not_active Expired
- 2002-04-05 PL PL02367301A patent/PL367301A1/pl unknown
- 2002-04-05 EP EP08167533A patent/EP2147930A3/en not_active Withdrawn
- 2002-04-05 EP EP10180109A patent/EP2289913A1/en not_active Withdrawn
- 2002-04-05 PL PL385189A patent/PL215401B1/pl unknown
- 2002-04-05 EP EP10180106A patent/EP2289912A1/en not_active Withdrawn
- 2002-04-05 CA CA2606839A patent/CA2606839C/en not_active Expired - Lifetime
- 2002-04-05 EP EP10180823A patent/EP2289919A1/en not_active Withdrawn
- 2002-04-05 EP EP10180193A patent/EP2289917A1/en not_active Withdrawn
- 2002-04-05 EP EP10180828A patent/EP2289921A1/en not_active Withdrawn
- 2002-04-05 EP EP08167531A patent/EP2147929A3/en not_active Ceased
- 2002-04-05 DK DK10181267.5T patent/DK2295464T3/en active
- 2002-04-05 EP EP10180838A patent/EP2289923A1/en not_active Withdrawn
- 2002-04-05 EE EEP200700052A patent/EE200700052A/xx unknown
- 2002-04-05 CN CN028089405A patent/CN1505525B/zh not_active Expired - Fee Related
- 2002-04-05 EP EP10181227A patent/EP2289932A1/en not_active Withdrawn
- 2002-04-05 EP EP10181267.5A patent/EP2295464B1/en not_active Expired - Lifetime
- 2002-04-05 AT AT02714667T patent/ATE415423T1/de active
- 2002-04-05 PL PL391615A patent/PL217858B1/pl unknown
- 2002-04-05 ES ES02714667T patent/ES2317999T3/es not_active Expired - Lifetime
- 2002-04-05 EP EP10180026A patent/EP2295457A1/en not_active Withdrawn
- 2002-04-05 CN CN2007101953989A patent/CN101284874B/zh not_active Expired - Lifetime
- 2002-04-05 EP EP10181213A patent/EP2289930A1/en not_active Withdrawn
- 2002-04-05 EP EP10180115A patent/EP2305707A1/en not_active Withdrawn
- 2002-04-05 EE EEP200300487A patent/EE200300487A/xx unknown
- 2002-04-05 EP EP10180826A patent/EP2289920A1/en not_active Withdrawn
- 2002-04-05 EP EP10180099A patent/EP2295458A1/en not_active Withdrawn
- 2002-04-05 EP EP10181263A patent/EP2295463A1/en not_active Withdrawn
- 2002-04-05 EP EP10181203A patent/EP2289929A1/en not_active Withdrawn
- 2002-04-05 EP EP10180176A patent/EP2305708A1/en not_active Withdrawn
2003
- 2003-10-07 IL IL158285A patent/IL158285A/en active IP Right Grant
2007
- 2007-12-20 IL IL188286A patent/IL188286A0/en unknown
2008
- 2008-01-25 JP JP2008015545A patent/JP2008169215A/ja not_active Withdrawn
- 2008-11-18 IL IL195356A patent/IL195356A0/en unknown
2009
- 2009-02-24 CY CY20091100202T patent/CY1108817T1/el unknown
- 2009-06-02 JP JP2009133383A patent/JP5270456B2/ja not_active Expired - Fee Related
2010
- 2010-10-26 JP JP2010239478A patent/JP5300820B2/ja not_active Expired - Lifetime
- 2010-10-26 JP JP2010239477A patent/JP5300819B2/ja not_active Expired - Lifetime
2013
- 2013-02-25 JP JP2013034312A patent/JP5613890B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP2289915A1 (en)	2011-03-02
EE200700052A (et)	2008-08-15
CN101284874B (zh)	2012-10-03
EP1918300A3 (en)	2009-06-17
JP5300820B2 (ja)	2013-09-25
CA2443223A1 (en)	2002-10-17
SE0103754L (sv)	2002-10-06
CA2443223C (en)	2013-11-26
IL195356A0 (en)	2009-08-03
IL188286A0 (en)	2008-03-20
JP5613890B2 (ja)	2014-10-29
EP2289930A1 (en)	2011-03-02
CN1505525A (zh)	2004-06-16
IL158285A0 (en)	2004-05-12
EP2289926A1 (en)	2011-03-02
CA2606839A1 (en)	2002-10-17
EP2006301A1 (en)	2008-12-24
JP2009191078A (ja)	2009-08-27
DK2006301T3 (da)	2011-09-12
CN101486766A (zh)	2009-07-22
WO2002080954A1 (en)	2002-10-17
RU2003132443A (ru)	2005-02-27
EP2289917A1 (en)	2011-03-02
EP2289928A1 (en)	2011-03-02
EP2295464A1 (en)	2011-03-16
AU2002246484A1 (en)	2002-10-21
EP2295457A1 (en)	2011-03-16
EP2289919A1 (en)	2011-03-02
ES2546293T3 (es)	2015-09-22
ATE510851T1 (de)	2011-06-15
EP2289933A1 (en)	2011-03-02
AU2002246484B8 (en)	2007-06-14
EP2305706A1 (en)	2011-04-06
JP2011063598A (ja)	2011-03-31
RU2296582C2 (ru)	2007-04-10
JP2004529143A (ja)	2004-09-24
CN101284874A (zh)	2008-10-15
PL215401B1 (pl)	2013-12-31
EP1383526B1 (en)	2008-11-26
EP2289923A1 (en)	2011-03-02
BR0208685A (pt)	2004-03-30
JP5300819B2 (ja)	2013-09-25
EP2289922A1 (en)	2011-03-02
EP2289934A1 (en)	2011-03-02
PL367301A1 (pl)	2005-02-21
EP2289916A1 (en)	2011-03-02
EP2289913A1 (en)	2011-03-02
EP2147680A2 (en)	2010-01-27
CN1505525B (zh)	2012-11-07
JP5270456B2 (ja)	2013-08-21
EP2289929A1 (en)	2011-03-02
EP2147928A3 (en)	2010-04-14
EP2006301B1 (en)	2011-05-25
EP2305707A1 (en)	2011-04-06
CN103122031A (zh)	2013-05-29
PL217858B1 (pl)	2014-08-29
CN103122031B (zh)	2015-07-22
DK2295464T3 (en)	2015-08-17
EP2295460B1 (en)	2015-06-03
EP2289920A1 (en)	2011-03-02
EP2289932A1 (en)	2011-03-02
EP2147929A2 (en)	2010-01-27
DK1383526T3 (da)	2009-03-30
EP2295459A1 (en)	2011-03-16
EP2305708A1 (en)	2011-04-06
JP2013144687A (ja)	2013-07-25
JP2011068654A (ja)	2011-04-07
EP2295461A1 (en)	2011-03-16
EP2147929A3 (en)	2010-04-14
EP2289934B1 (en)	2013-11-13
ES2317999T3 (es)	2009-05-01
EP2295462A1 (en)	2011-03-16
EP1383526A1 (en)	2004-01-28
EP2289921A1 (en)	2011-03-02
EP2289931A1 (en)	2011-03-02
EP2289914A1 (en)	2011-03-02
EP2147930A3 (en)	2010-04-14
CY1108817T1 (el)	2014-04-09
SE0103754D0 (sv)	2001-11-09
EP2295464B1 (en)	2015-06-03
EP2289918A1 (en)	2011-03-02
EP2289912A1 (en)	2011-03-02
EP2289927A1 (en)	2011-03-02
ATE415423T1 (de)	2008-12-15
EP2295458A1 (en)	2011-03-16
CA2827167A1 (en)	2002-10-17
IL158285A (en)	2009-12-24
JP2008169215A (ja)	2008-07-24
EP1918300A2 (en)	2008-05-07
EE200300487A (et)	2004-02-16
EP2147930A2 (en)	2010-01-27
AU2002246484B2 (en)	2007-04-19
EP2289925A1 (en)	2011-03-02
EP2147928A2 (en)	2010-01-27
DE60230029D1 (de)	2009-01-08
EP2295460A1 (en)	2011-03-16
EP2289935A1 (en)	2011-03-02
EP2295463A1 (en)	2011-03-16
EP2147680A3 (en)	2010-04-14
EP2289924A1 (en)	2011-03-02
CA2606839C (en)	2015-06-09
PT1383526E (pt)	2009-02-27

Legal Events

Date	Code	Title	Description
2014-03-31	DISC	Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
PL400308A1 (pl)	2012-12-17	Terapia immunizacyjna w oparciu o peptydy do leczenia miazdzycy oraz w oparciu o peptydy do okreslania odpowiedzi odpornosci przeciwko utlenionym lipoproteinom o niskiej gestosci
DE69738138D1 (de)	2007-10-25	Induktion von immunologischer Toleranz gegen einen therapeutischen Antikörper durch Varianten des therapeutischen Antikörpers
AT500379A3 (de)	2009-02-15	Tau-proteine
DE60233955D1 (de)	2009-11-19	Spezifische bindungsmittel von human angiopoietin-2
CY1112229T1 (el)	2015-12-09	Αντισωματα κατευθυνομενα εναντι οξειδωμενης απολιποπρωτεϊνης β
IS7601A (is)	2004-12-16	Neisser-bóluefnasamsetningar sem innihalda blönduaf mótefnavökvum
AU5810201A (en)	2001-11-20	Immunogenic polypeptides encoded by mage minigenes and uses thereof
WO2004030607A3 (en)	2004-06-24	Peptide-based passive immunization therapy for treatment of atherosclerosis
DE69431603D1 (de)	2002-11-28	Oligopeptide hergeleitet von fragmenten des c-reaktiven proteins
AU2003225900A1 (en)	2003-10-08	Antibody disulfide isomers, use thereof, and methods of analyzing same
DE69333111D1 (de)	2003-08-28	Natürliche menschliche igm antikörper
WO2002051237A3 (en)	2004-02-26	Helicobacter proteins, nucleic acids and uses thereof
WO2002023202A3 (en)	2003-05-22	Method to identify antibody targets based on mass spectrometry (maldi-tof)
BRPI0216033B8 (pt)	2021-05-25	"terapia de imunização à base de peptídio para tratamento de arteriosclerose"
ATE329898T1 (de)	2006-07-15	Kombinationspräparat zur therapie von immunologischen erkrankungen
SE0202959D0 (sv)	2002-10-04	Peptide-Base passive immunization therapy for treatment of atherosclerosis
UY27007A1 (es)	2003-05-30	Anticuerpos humanos enlazados a il-12 humana y métodos para producirlos